ST Pharm Co.,Ltd. (KOSDAQ:237690)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Clinical Trial Contract Research	44.94B	30.36B	33.76B	40.32B	27.16B
Clinical Trial Contract Research Growth	48.01%	-10.07%	-16.26%	48.46%	79.66%
Raw Material Manufacturing	293.18B	244.07B	251.56B	209.27B	139.14B
Raw Material Manufacturing Growth	20.12%	-2.98%	20.21%	50.40%	27.59%
Consolidation Adjustment	-6.44B	-681.99M	-326.10M	-263.41M	-652.92M
Total	331.68B	273.75B	284.99B	249.32B	165.64B
Total Growth	21.16%	-3.94%	14.31%	50.52%	33.47%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Switzerland	104.46B	95.47B	98.64B	110.25B	61.81B
Switzerland Growth	9.42%	-3.21%	-10.53%	78.39%	129.98%
USA	122.43B	84.74B	51.95B	30.31B	22.52B
USA Growth	44.48%	63.11%	71.42%	34.60%	11.90%
Korea	29.99B	33.88B	39.84B	52.57B	45.47B
Korea Growth	-11.49%	-14.96%	-24.22%	15.61%	2.28%
Other Countries	74.80B	59.66B	66.28B	55.54B	35.85B
Other Countries Growth	25.37%	-9.98%	19.34%	54.92%	21.22%
Belgium	-	-	28.28B	658.69M	-
Belgium Growth	-	-	4194.11%	-	-
Total	331.68B	273.75B	284.99B	249.32B	165.64B
Total Growth	21.16%	-3.94%	14.31%	50.52%	33.47%

Source: S&P Global Market Intelligence.